Hoitt Jason
SEC CIK 1762572 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | Chief Patient Off | 10.3K | — | $119.3K | 2 | 2026-03-15 | 2026-03-17 |
Most active insiders at STOK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Krainer Adrian R. | Dir | — | $3.90M |
| 2 | Kaye Edward M. MD | Dir | — | $3.18M |
| 3 | Ticho Barry | Chief MEDICAL Off | — | $1.98M |
| 4 | Allan Jonathan | GC, CORP SEC | — | $1.56M |
| 5 | TZIANABOS ARTHUR | Interim Executive COB, Dir | — | $174.2K |
| 6 | Leggett Thomas | CFO | — | $147.1K |
| 7 | Hoitt Jason | Chief Patient Off | — | $119.3K |
| 8 | LEVIN ARTHUR A | Dir | — | $22.3K |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-19 | 2026-03-17+ | STOK | Stoke Therapeutics, Inc. | Hoitt Jason | Chief Patient Off | S - Sale | $32.14 | -3,712 | 10.3K | -27% | -$119.3K |
| D | 2026-03-17 | 2026-03-15 | STOK | Stoke Therapeutics, Inc. | Hoitt Jason | Chief Patient Off | M - OptEx | $0.00 | +10.0K | 14.0K | +251% | $0 |
Purchase Sale Sale after option exercise All abbreviations